-
Mashup Score: 22
We would like to thank James Howard et al. for their insightful comments on our paper titled “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 62The Role of Chimeric Antigen Receptor T‐Cell Therapy in Immune‐Mediated Neurological Diseases - 5 month(s) ago
Despite the use of ‘high efficacy’ disease-modifying therapies, disease activity and clinical progression of different immune-mediated neurological diseases continue for some patients, resulting in a…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
#CART in Immune-Mediated Neurological Diseases, including MS, NMO, MG, CIDP, stiff person syndrome, might be an effective option for patients, avoiding the need for long-term immunosuppressant medications. A new manuscript on behalf of @TheEBMT ADWP. https://t.co/HejUBhAcdc
-
-
Mashup Score: 45Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus - 9 month(s) ago
Nature Communications – Systemic Lupus Erythematosus (SLE) is a chronic and progressive autoimmune disease characterized by abnormally activated B cells causing organ damage. Here authors introduce…
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet-
Our @SanRaffaeleMI #CARTregs study in #autoimmunediseases and #systemiclupuserythematosus is now available in @NatureComms: https://t.co/f8PlkA2siC
-
-
Mashup Score: 25
Bone Marrow Transplantation – Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell…
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet-
Harmonized definitions to facilitate research and international collaboration among transplant researchers and across transplant registries. @BMTjournal @TheEBMT @CIBMTR @APBMT_BCT @ASTCT https://t.co/ETUoUA4rCm
-
-
Mashup Score: 0Dominique FARGE on LinkedIn: Dear Colleagues, The International Society for Cell and Gene Therapy… - 1 year(s) ago
Dear Colleagues, The International Society for Cell and Gene Therapy (ISCT) Institute of Training and Development – The Global Leader in Cell and Gene Therapy…
Source: www.linkedin.comCategories: General Medicine News, Hematologists1Tweet-
https://t.co/JqAY94DnBA
-
-
Mashup Score: 1German Lymphoma Alliance - 1 year(s) ago
The clinical course of mantle cell lymphoma (MCL) is highly variable. Lower age, better performance status, lower serum lactate-dehydrogenase (LDH) activity, and lower white blood cell (WBC) count at first diagnosis have been shown to be associated with longer progression-free and overall survival in patients with MCL suitable for moderately intensive chemotherapy. Furthermore, the tumour cell proliferation rate Ki-67 index has been identified as strong prognostic marker additional to clinical patient
Source: www.german-lymphoma-alliance.deCategories: Hematologists1, Latest HeadlinesTweet-
RT @HematoRules: @MSubklewe #ITC23 ➡️ CAR-HEMATOTOX … great tool ✅ https://t.co/bTlC7CITQY ➡️ Antibiotics and #ICATH … interesting relati…
-
-
Mashup Score: 3Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: a pilot experience - 2 year(s) ago
: In the era of JAK inhibitors, allogeneic stem cell transplantation (HSCT) remains the only curative treatment for patients with Myelofibrosis (MF). …
Source: www.sciencedirect.comCategories: Hematologists1, Latest HeadlinesTweet-
The @SanRaffaeleMI experience with splenic irradiation prior to allogeneic transplant with treo-based conditioning for #myelofibrosis in the era of JAK-inhibitors: https://t.co/MakZH2KZQV
-
-
Mashup Score: 1
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in SARS-CoV-2 positive candidates is usually delayed until the clinical resolution of the infection’s symptoms and a negative nasopharyngeal molecular test. However, prolonged SARS-CoV-2 positivity has been frequently observed in haematological malignancies, thus representing a challenge for the timing of transplant procedures. Here,…
Source: FrontiersCategories: Hematologists1, Latest HeadlinesTweet-
RT @AcerbisAndrea: https://t.co/7CFur2rCBY A case of alloHCT in Covid-19 ✅️ balance between inf and leuk ✅️ SARS-CoV-2 preventive therapies…
-
-
Mashup Score: 1
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in SARS-CoV-2 positive candidates is usually delayed until the clinical resolution of the infection’s symptoms and a negative nasopharyngeal molecular test. However, prolonged SARS-CoV-2 positivity has been frequently observed in haematological malignancies, thus representing a challenge for the timing of transplant procedures. Here,…
Source: FrontiersCategories: Hematologists1, Latest HeadlinesTweet-
RT @giorgio_orofino: https://t.co/ogNsfaQHWD Sars-Cov2 🦠 and HSCT 🩸—> 🚦 Check our case report out in @FrontImmunol with a favorable outco…
-
-
Mashup Score: 0Midterm Meeting on New indications in Immune Dysregulatory, Autoinflammatory and Autoimmune Diseases - 2 year(s) ago
Dates: 22 – 24 June 2023 Location: Brescia, Italy Venue: Auditorium di Santa Giulia We are pleased to announce a unique initiative. Three EBMT working parties (Autoimmune, Inborn Errors and Paediatric) will all meet on 22 to 24 June 2023 for the Midterm Meeting in Immune Dysregulatory, Autoinflammatory and Autoimmune Diseases. The meeting will be held at the Auditorium di S.Giulia in Brescia…
Source: EBMTCategories: Hematologists1, Latest HeadlinesTweet-
Last days to register for free at @TheEBMT Midterm Meeting in Brescia (Italy) https://t.co/2EBHqzXSDo @TheEBMT_Trainee @TheEBMT_Nurses @JACIE_EBMT https://t.co/lmWN4N3mT3
-
The CAR T cell use in autoimmune diseases is an evolving field. Here some suggestions from @TheEBMT autoimmune diseases working party and harmonization committee in addition to our recent recommendations (DOI: 10.1016/j.eclinm.2024.102476): https://t.co/p6e70uabNx